StreetInsider.com News Articles

Form 4 BRUKER CORP For: Jun 15 Filed by: Munch Mark

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654279.html

Form 4 BRUKER CORP For: Jun 15 Filed by: Munch Mark

Tue, 16 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260616/26654279.html

Form 144 BRUKER CORP Filed by: Munch Mark

Mon, 15 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260615/26648007.html

Form 144 BRUKER CORP Filed by: Munch Mark

Mon, 15 Jun 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260615/26648007.html

Bruker (BRKR) files mixed shelf

Fri, 12 Jun 2026 16:22:22 -0400

Bruker (NASDAQ: BRKR) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Depositary Shares

Subscription Rights

Purchase Contracts

Bruker (BRKR) files mixed shelf

Fri, 12 Jun 2026 16:22:22 -0400

Bruker (NASDAQ: BRKR) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Depositary Shares

Subscription Rights

Purchase Contracts

Form S-3ASR BRUKER CORP

Fri, 12 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260612/26641007.html

Form S-3ASR BRUKER CORP

Fri, 12 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260612/26641007.html

Bruker demonstrates expanded microbiology diagnostics portfolio at ASM

Thu, 04 Jun 2026 07:03:02 -0400

Bruker Corporation (NASDAQ: BRKR) presented its expanded microbiology and infection diagnostics portfolio at ASM Microbe 2026, showcasing developments in microbial identification, sepsis diagnostics, molecular testing, and next-generation sequencing workflows.

The company highlighted enhanced clinical capabilities of its MALDI Biotyper CA System through FDA Claims 7 and 8, which support broader microbial identification in clinical laboratories. The system now includes MBT Compass HT CA software, MBT FAST Shuttle US IVD, and an expanded FDA-cleared reference library covering 549 clinically validated microbial species across bacteria, anaerobes, and yeasts.

Bruker introduced several new solutions for MALDI Biotyper RUO/GP systems to the U.S. market, including the

Bruker demonstrates expanded microbiology diagnostics portfolio at ASM

Thu, 04 Jun 2026 07:03:02 -0400

Bruker introduced several new solutions for MALDI Biotyper RUO/GP systems to the U.S. market, including the

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

WASHINGTON--(BUSINESS WIRE)-- At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

Thu, 04 Jun 2026 07:00:00 -0400

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604057503/en/

MALDI Biotyper® sirius CA System, delivering high‑throughput

Bruker launches timsMRMS mass spectrometry platform for energy research

Tue, 02 Jun 2026 11:29:43 -0400

Bruker Corporation (NASDAQ: BRKR) announced the launch of its timsMRMS mass spectrometry system at the ASMS conference. The platform combines Trapped Ion Mobility Spectrometry with Magnetic Resonance Mass Spectrometry for analyzing complex molecular structures in energy applications.

The system provides mass resolution exceeding 10 million and sub-parts-per-million mass accuracy, according to the company's press release. The technology targets researchers working in petroleomics, sustainable fuels, and energy storage materials.

The timsMRMS platform addresses two primary applications in energy research. For lithium battery development, the system analyzes electrolyte formulations and molecular changes during charge-discharge cycles. For biofuels research, it examines the molecular composition of

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

SAN DIEGO--(BUSINESS WIRE)-- At ASMS, Bruker Corporation (Nasdaq: BRKR) announced the launch of the new timsMRMS system, designed to empower researchers in petroleomics, sustainable fuels and advanced energy storage. The timsMRMS is an innovative platform that combines Trapped Ion Mobility Spectrometry (TIMS) with extreme-resolution Magnetic Resonance Mass Spectrometry (MRMS), to unravel the complex molecular makeup of challenging fossil fuels and green energy materials. It accomplishes this with unparalleled mass resolution (>10M) and sub-parts-per-million mass accuracy, plus isotope fine structure identification-confirmation, which enables the most confident identification of molecular species in ultra-complex mixtures.

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

Tue, 02 Jun 2026 11:24:00 -0400

This

Bruker (BRKR) PT Raised to $64 at BofA Securities

Tue, 02 Jun 2026 05:12:14 -0400

BofA Securities analyst Michael Ryskin raised the price target on Bruker (NASDAQ: BRKR) to $64.00 (from $49.00) while maintaining a Buy rating.

Wolfe Research Assumes Bruker (BRKR) at Peerperform

Mon, 01 Jun 2026 16:27:27 -0400

(Updated - June 1, 2026 4:27 PM EDT)

Wolfe Research analyst Mike Polark assumes coverage on Bruker (NASDAQ: BRKR) with a Peerperform rating.

The analyst comments "BRKR has gotten really expensive versus the group really quickly – is that a semis-derivative trade? Maybe – it’s 10% of BRKR and that’s top for mix amongst this new coverage. Been a tough 12 months for BRKR – growth declines – but these challenges now are the ‘easy comps’ ahead. However, a recovery clearly guided on growth and margin and so environment needs to cooperate/be less bad to achieve current estimates. So this dynamic, paired

Wolfe Research Assumes Bruker (BRKR) at Peerperform

Mon, 01 Jun 2026 16:27:27 -0400

(Updated - June 1, 2026 4:27 PM EDT)

Wolfe Research analyst Mike Polark assumes coverage on Bruker (NASDAQ: BRKR) with a Peerperform rating.

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Ena

Mon, 01 Jun 2026 07:00:00 -0400

Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing

Launch of eXtreme 10M resolution novel timsMRMS™ mass spectrometer for ultra-complex mixture analysis in energy industry and life-science research
Breakthrough timsUltra™ AIP bottom-up proteomics performance: instrument improvements, new razor-PASEF™ methods and Spectronaut 21 software enable ID and LFQ beyond 10,000 proteins in cell lines and tissue, with >6,500 proteins at 500 SPD, and leading plasma proteomics performance with single-particle P2 enrichment
Revolutionary timsOmni™ enables unmatched multi-stage, ultra-sensitive trapped ExD (tExD) fragmentation for deeper structural and functional characterization of proteoforms and PTMs, with

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Ena

Mon, 01 Jun 2026 07:00:00 -0400

Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing

Launch of eXtreme 10M resolution novel timsMRMS™ mass spectrometer for ultra-complex mixture analysis in energy industry and life-science research

Breakthrough timsUltra™ AIP bottom-up proteomics performance: instrument improvements, new razor-PASEF™ methods and Spectronaut 21 software enable ID and LFQ beyond 10,000 proteins in cell lines and tissue, with >6,500 proteins at 500 SPD, and leading plasma proteomics performance with single-particle P2 enrichment

Revolutionary timsOmni™ enables unmatched multi-stage, ultra-sensitive trapped ExD (tExD) fragmentation for deeper structural and functional characterization of proteoforms and PTMs, with

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Ena

Mon, 01 Jun 2026 07:00:00 -0400

Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing

Launch of eXtreme 10M resolution novel timsMRMS™ mass spectrometer for ultra-complex mixture analysis in energy industry and life-science research

Breakthrough timsUltra™ AIP bottom-up proteomics performance: instrument improvements, new razor-PASEF™ methods and Spectronaut 21 software enable ID and LFQ beyond 10,000 proteins in cell lines and tissue, with >6,500 proteins at 500 SPD, and leading plasma proteomics performance with single-particle P2 enrichment

Revolutionary timsOmni™ enables unmatched multi-stage, ultra-sensitive trapped ExD (tExD) fragmentation for deeper structural and functional characterization of proteoforms and PTMs, with